Aytu BioPharma Inc. (AYTU)
NASDAQ: AYTU
· Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.24
1.36%
After-hours: Aug 15, 2025, 05:41 PM EDT
Aytu BioPharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 18.45M | 16.22M | 16.57M | 17.98M | 17.99M | 22.93M | 22.1M | 30.73M | 22.73M | 26.28M | 27.66M | 27.45M | 24.2M | 23.13M | 21.9M | 23.48M | 13.48M | 15.15M | 13.52M |
Cost of Revenue | 5.65M | 5.43M | 4.59M | 6.07M | 6.3M | 6.73M | 7.32M | 12.17M | 9.99M | 8.99M | 9.62M | 12.61M | 11.51M | 10.83M | 9.44M | 12.18M | 13.68M | 6M | 3.82M |
Gross Profit | 12.81M | 10.79M | 11.98M | 11.91M | 11.69M | 16.2M | 14.78M | 18.56M | 12.74M | 17.29M | 18.03M | 14.84M | 12.69M | 12.3M | 12.46M | 11.3M | -200.01K | 9.15M | 9.7M |
Operating Income | 2.42M | -1.7M | -930K | -3.65M | -2.46M | 2.36M | -1.5M | 169K | -9.29M | -4.19M | -1.52M | 2.71M | 34.1M | -11.29M | -27.7M | -24.07M | -25.67M | -5.58M | -3.56M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 3.82M | 382K | 1.5M | -3.92M | -2.64M | 608K | -8.12M | -2.46M | -7.2M | -6.69M | -2.88M | -17.7M | -53.07M | -11.55M | -27.96M | -18.74M | -25.46M | -9.53M | -4.31M |
Net Income | 3.99M | 788K | 1.47M | -4.62M | -2.89M | -220K | -8.12M | -2.46M | -7.2M | -6.69M | -700K | -16.09M | -53.29M | -11.55M | -27.85M | -19M | -25.46M | -9.53M | -4.31M |
Selling & General & Admin | 9.3M | 9.72M | 10.78M | 11.09M | 11.99M | 12.02M | 14.38M | 14.1M | 19.98M | 18.58M | 17.42M | 17.4M | 17.36M | 17.61M | 17.51M | 20.73M | 12.6M | 11.29M | 11.25M |
Research & Development | 162K | 522K | 426K | 1.04M | 619K | 524K | 604K | 465K | 856K | 1.71M | 1.06M | 3.7M | 3.73M | 4.92M | 2.1M | 4.76M | 389.26K | 286.57K | 182.87K |
Other Expenses | n/a | 2.24M | n/a | 3.42M | n/a | -1.18M | n/a | -1.25M | 1.2M | 1.2M | 1.2M | 853K | 1.06M | 20K | -40K | -495K | -425.43K | -378.96K | -751.54K |
Operating Expenses | 9.46M | 12.48M | 11.21M | 15.56M | 12.61M | 12.54M | 14.98M | 15.76M | 22.04M | 21.49M | 19.68M | 21.95M | 22.14M | 23.59M | 20.7M | 26.75M | 19.11M | 14.72M | 13.26M |
Interest Expense | -900K | 1.08M | 994K | n/a | n/a | 1.27M | n/a | n/a | n/a | 2.5M | 1.36M | 20.36M | 87.18M | 534K | 39.38M | 14.65M | n/a | n/a | n/a |
Selling & Marketing Expenses | 5.19M | 5.27M | 5.66M | 6.41M | 6.55M | 6.58M | 7.42M | 7.98M | 12.8M | 10.56M | 10.1M | 10.01M | 9.74M | 9.66M | 9.3M | 12.18M | 6.6M | 5.71M | 5.83M |
Cost & Expenses | 15.11M | 15.68M | 17.5M | 21.63M | 18.91M | 20.57M | 22.3M | 27.92M | 32.02M | 30.47M | 29.31M | 34.55M | 33.66M | 34.42M | 30.14M | 38.93M | 32.79M | 20.72M | 17.08M |
Income Tax Expense | 122K | -283K | 405K | 695K | -245K | 828K | n/a | n/a | -1.36M | n/a | 1.36M | 20.36M | 87.18M | -3K | -107K | 259K | 11.87M | 7.52M | 746.87K |
Shares Outstanding (Basic) | 6.13M | 6.13M | 7.37M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M | 3.73M | 3.11M | 2.52M | 1.8M | 1.48M | 1.32M | 60K | 1.18M | 900K | 660K | 610K |
Shares Outstanding (Diluted) | 8.2M | 8.49M | 9.1M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M | 3.73M | 3.11M | 2.52M | 1.8M | 1.48M | 1.32M | 60K | 1.18M | 900K | 660K | 610K |
EPS (Basic) | 0.01 | 0.13 | 0.20 | -0.83 | -0.52 | -0.04 | -1.48 | -0.59 | -1.93 | -2.15 | -0.28 | -8.95 | -35.9 | -8.74 | -435.2 | -16.2 | -28.2 | -14.4 | -7 |
EPS (Diluted) | 0.01 | -0.26 | 0.16 | -0.83 | -0.52 | -0.04 | -1.48 | -0.59 | -1.93 | -2.15 | -0.28 | -8.95 | -35.9 | -8.74 | -435.2 | -16.2 | -28.2 | -14.4 | -7 |
EBITDA | 2.42M | 2.8M | 3.92M | -5.98M | -842K | 4.54M | 726K | -646K | -7.1M | -1.99M | 648K | -6.88M | -6.88M | -8.62M | -5.57M | -15.91M | -13.05M | -2.39M | -1.52M |
EBIT | n/a | 1.46M | 2.49M | -7.92M | -2.22M | 2.67M | -1.5M | -2.46M | -9.29M | -4.19M | -1.65M | -7.1M | -9.46M | -11.29M | -8.25M | -11.17M | -15.03M | -4.26M | -3.56M |
Depreciation & Amortization | n/a | 1.34M | 1.43M | 1.94M | 1.8M | 1.79M | 2.23M | 1.81M | 3M | 1.9M | 2.33M | 2.25M | 2.65M | 2.67M | 2.68M | 2.83M | 1.65M | 1.87M | 2.04M |